Hematology | Clinical

Unmet Needs for Managing CRS and ICANS Due to CAR T-Cell Therapy

September 01, 2022

Nicolas Gazeau, MS, discusses next steps and unmet needs following a positive retrospective study of anakinra for the management of neurotoxicity and cytokine release syndrome in patients who received chimeric antigen receptor T-cell therapy.

Couriel Assesses the Available Data for Treatment of Acute GVHD

August 26, 2022

During a Targeted Oncology case-based roundtable event, Daniel R. Couriel, MD, MS, MBA, discussed how to predict risk of acute graft-vs-host-disease and manage its effects on patients with hematologic malignancies.